High HbA1c levels in early to mid-pregnancy associated with adverse pregnancy outcomes: Study
Hyperglycemia during pregnancy poses risks to both mothers and infants, necessitating vigilant monitoring. A recent study, a secondary analysis of the AMANHI cohort, investigates the correlation between early to mid-pregnancy HbA1c levels and pregnancy complications in three South Asian and Sub-Saharan African countries. Elevated maternal HbA1c levels emerged as an independent risk factor for adverse pregnancy outcomes in South Asia and Sub-Saharan Africa.
This study was published in the journal BMC Pregnancy and Childbirth by Muhammad Imran Nisar and colleagues. The AMANHI cohort enrolled 10,001 pregnant women across Bangladesh, Pakistan, and Tanzania between May 2014 and June 2018. HbA1c assays were conducted during the early gestational period, and epidemiological data were collected throughout pregnancy. Maternal outcomes were tracked, with a focus on adverse events.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.